Skip to main content
. 2023 Nov 29;15(23):5631. doi: 10.3390/cancers15235631

Table 4.

Clinical background of cases of non-small cell lung cancer stained with MSI-1.

Case MSI-1 Syn CD56 ChrA ISNM1 Type pStage Smoke (BI) Rec
1 3+ 0 2 0 1 Ad (pap) IA2 +(1600) -
2 2+ 0 0 0 0 Sq IA2 +(1000) -
3 2+ 0 0 0 1 Sq IB +(860) -
4 2+ 1 0 0 0 Sq IB +(600) -
5 1+ 0 0 0 1 Sq IIB +(3000) -
6 1+ 0 2 0 0 Sq IIIB +(2700) +
7 1+ 0 1 0 0 Sq IB +(1920) -
8 1+ 0 1 0 1 Sq IB +(1800) -
9 1+ 1 0 0 0 Sq IIIA +(1380) +
10 1+ 0 0 0 1 Ad (aci) IB +(1320) -
11 1+ 0 1 0 0 Sq IB +(1200) +
12 1+ 0 0 1 1 Ad (pap) IB +(1075) -
13 1+ 0 0 0 0 Sq IB +(660) -
14 1+ 0 0 0 0 Sq IA2 +(600) -

MSI-1 = Musashi-1, Syn = synaptophysin, ChrA = chromogranin-A, INSM1 = insulinoma-associated protein-1, pStage = pathological stage, BI = Brinkman index, rec = recurrence, Ad = adenocarcinoma, Sq = squamous cell carcinoma, pap = papillary predominant, aci = acinar predominant.